Redmond Asset Management LLC lessened its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 37.5% during the third quarter, Holdings Channel.com reports. The firm owned 20,159 shares of the industrial products company’s stock after selling 12,091 shares during the quarter. Redmond Asset Management LLC’s holdings in Xylem were worth $2,042,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. North Star Investment Management Corp. lifted its holdings in shares of Xylem by 21.4% in the 3rd quarter. North Star Investment Management Corp. now owns 1,701 shares of the industrial products company’s stock valued at $172,000 after buying an additional 300 shares during the period. William Mack & Associates Inc. acquired a new position in Xylem during the third quarter worth $25,000. Generali Asset Management SPA SGR grew its holdings in Xylem by 2.0% during the third quarter. Generali Asset Management SPA SGR now owns 14,248 shares of the industrial products company’s stock worth $1,443,000 after acquiring an additional 273 shares during the period. Oppenheimer & Co. Inc. grew its holdings in Xylem by 5.4% during the third quarter. Oppenheimer & Co. Inc. now owns 98,228 shares of the industrial products company’s stock worth $9,948,000 after acquiring an additional 5,023 shares during the period. Finally, Apollon Wealth Management LLC raised its position in Xylem by 14.8% in the third quarter. Apollon Wealth Management LLC now owns 27,526 shares of the industrial products company’s stock worth $2,788,000 after acquiring an additional 3,541 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have commented on XYL. Weiss Ratings downgraded Xylem from a “hold (c)” rating to a “sell (d)” rating in a report on Wednesday. BNP Paribas Exane decreased their target price on shares of Xylem from $145.00 to $135.00 and set an “outperform” rating on the stock in a research report on Wednesday. Stifel Nicolaus lowered their price target on shares of Xylem from $141.00 to $114.00 and set a “buy” rating on the stock in a research note on Wednesday. Oppenheimer cut their price target on shares of Xylem from $150.00 to $135.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, The Goldman Sachs Group reduced their price objective on shares of Xylem from $160.00 to $138.00 and set a “buy” rating for the company in a research note on Wednesday. Ten investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $122.31.
View Our Latest Stock Report on XYL
Xylem Price Performance
Shares of NYSE:XYL opened at $88.31 on Thursday. The firm has a market capitalization of $20.62 billion, a price-to-earnings ratio of 21.03, a price-to-earnings-growth ratio of 1.75 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24. The business’s 50 day simple moving average is $105.98 and its 200-day simple moving average is $118.05. Xylem Inc. has a 12 month low of $87.40 and a 12 month high of $154.27.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.28 billion. During the same period in the previous year, the business earned $1.37 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, equities analysts forecast that Xylem Inc. will post 5.65 earnings per share for the current fiscal year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were issued a $0.43 dividend. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem’s dividend payout ratio is 40.95%.
Trending Headlines about Xylem
Here are the key news stories impacting Xylem this week:
- Positive Sentiment: Despite the near-term concerns, Xylem reported adjusted earnings of $1.44 per share, up from $1.37 a year earlier, while orders increased approximately 10%. Several firms still see substantial longer-term upside: Citigroup maintained a “buy” rating with a $130 target, BNP Paribas Exane retained “outperform” at $135, and Oppenheimer kept “outperform” at $135. Citigroup analyst action
- Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring, which could improve focus and efficiency over time but may create execution costs and disruption in the near term. Xylem restructuring article
- Negative Sentiment: Third-quarter revenue was $2.20 billion, about $80 million below expectations and down 3% year over year; adjusted EPS also narrowly missed consensus. Weakness in metering and project timing contributed to the shortfall. Xylem Q3 revenue miss
- Negative Sentiment: Management lowered its 2026 revenue and profit outlook and issued cautious fourth-quarter expectations, citing customer pullbacks and ongoing operational headwinds. The guidance cut prompted multiple target reductions, including RBC to $125, Stifel to $114, and JPMorgan to $90; JPMorgan also downgraded the stock to “underweight.” Xylem outlook reduction
- Negative Sentiment: Put-option purchases were unusually heavy, rising roughly 358% above average daily volume, signaling increased hedging or bearish speculation. In addition, Levi & Korsinsky announced an investigation into potential securities-law violations related to shareholder losses. Xylem investigation notice
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.
The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.
See Also
- Five stocks we like better than Xylem
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
